FdaApplication

ANDA 203649

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSANDOZ INC
application_typeANDA
approval_date2017-11-30

Products (4)

ProductActive ingredientStrengthDosage form
TREPROSTINILTREPROSTINIL10MG/MLINJECTABLE;INTRAVENOUS, SUBCUTANEOUS
TREPROSTINILTREPROSTINIL5MG/MLINJECTABLE;INTRAVENOUS, SUBCUTANEOUS
TREPROSTINILTREPROSTINIL2.5MG/MLINJECTABLE;INTRAVENOUS, SUBCUTANEOUS
TREPROSTINILTREPROSTINIL1MG/MLINJECTABLE;INTRAVENOUS, SUBCUTANEOUS

4 products